Avalo Therapeutics Inc.

4.78
-0.10 (-2.05%)
At close: Apr 25, 2025, 3:59 PM
4.67
-2.30%
After-hours: Apr 25, 2025, 04:21 PM EDT

Avalo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
134.55M 7.42M 13.17M 54.59M 18.92M 3.61M 10.65M 2.47M 5.13M
n/a n/a n/a n/a n/a 7.63M n/a n/a n/a
n/a n/a 131K 227K 148.64K 101.94K 81.72K 131.35K 62.83K
131K 131K 131K 1.23M 149K 102K -91.24K 131.35K 173.00
611K 136K 1.92M 4.8M 2.18M n/a 822.33K 2.94M 132.47K
n/a n/a 20K 38K 3K 21K 1.11M 382.15K 11K
3.73M 844K 1.3M 51K 2.25M 1.2M 9.41M 4.18M 11.11K
138.89M 8.39M 16.42M 61.84M 26M 17.72M 21.93M 10.99M 5.66M
1.21M 1.97M 2.41M 2.69M 1.61M 1.45M 586.51K 44.61K 43K
10.5M 10.5M 14.41M 14.45M 15.99M 16.84M 47.65M 31.96M n/a
11.84M 12.6M 16.95M 18.37M 17.75M 18.39M 48.32M 32.13M 106K
150.73M 20.99M 33.37M 80.21M 43.76M 36.11M 70.25M 43.12M 5.77M
283K 446K 2.88M 3.37M 2.57M 2.08M 1.45M 1.3M 1.01M
n/a n/a 88K 16.02M 10.88M -155.81K 2.03M n/a 942.57K
n/a n/a 5.93M n/a n/a n/a n/a n/a 2.35M
6.11M 3.06M 9.98M 1.74M 3.36M 9.93M 21.14M 8.71M 675.39K
6.96M 4.62M 22.11M 19.89M 15.22M 12.16M 26.22M 11.41M 4.31M
n/a n/a 13.49M 32.83M n/a n/a n/a n/a n/a
10.47M 8.92M 8.54M 4.3M 3.97M 1.76M 23.06M 3.85M 1.25M
10.74M 9.07M 22.17M 37.24M 3.97M 2.95M 23.13M 3.86M 1.25M
17.7M 13.69M 44.28M 57.13M 19.19M 15.11M 49.34M 15.26M 5.56M
568K 537K 19.42M 32.83M 426.35K 1.27M 15.38M n/a 2.35M
10K 1K 9K 113K 75K 44K 40.8K 2.69M 9.43K
-370.26M -335.13M -303.82M -262.17M -177.79M -114.29M -98.22M -58.17M -70.04M
n/a n/a n/a n/a -0.00 -0.00 n/a 2.66M n/a
133.03M 7.3M -10.91M 23.08M 24.56M 21M 20.91M 27.86M 207K
n/a 131K 131K 227K 148.64K 7.63M 81.72K 131.35K 62.83K